jeudi 23 mars 2017

Onco Actu du 23 mars 2017


3.1 Tabac


Global smoking rates have fallen since introduction of international tobacco control strategy [Cancer Research UK]

3.4 Chimioprévention


Postmenopausal women with a family history of breast cancer should be offered anastrozole, says NICE in updated guidance [NICE]


NICE backs use of drugs for breast cancer prevention [PharmaTimes]

5.2 Pharma


Striving to vanquish leukemia [Novartis]

5.2.1 Pharma - Partenariats


GSK and Regeneron to mine gene data from 500,000 Britons [Reuters]

5.2.3 Pharma - économie


BioClin raises $30M Series B round for bladder cancer candidate [FierceBiotech]


BioClin Gets $30M to Back More Bladder Cancer Drug Trials [Xconomy]


BioClin scores a $30M raise from marquee investors to fuel mid-stage work on a new cancer drug [EndPoints]


Three considerations for the pharma industry as President Trump focuses on drug pricing [EndPoints]

5.3 Traitements - FDA, EMA, NICE...


Call for experts in anonymisation of clinical data [EMA]

5.4 Traitements - Economie


Cost effective but unaffordable: an emerging challenge for health systems [BMJ]

6. Lutte contre les cancers


U.S. Cancer Care System Poised for Transformation, but Challenges Loom Large [ASCO]

6.1 Observation


The pill provides 'lifelong protection against some cancers' [NHS Choices]

6.10.1 Politiques (USA)


Slashing the NIH budget won’t keep America first in the fight against cancer [STAT]


The Need for Publicly Funded Science [Neurologica]

6.12 Ethique


With patients demanding experimental drugs, ‘right to try’ is becoming the law of the land [STAT]

6.2 Implants mammaires


Breast Implants Linked To Rare Blood Cancer In Small Proportion Of Women [NPR]


FDA links very rare cancer, 9 deaths, to breast implants [STAT]

6.5 Médecines alternatives


Naturopaths cynically use the murder of a quack to promote naturopathic licensure [Restpectful Insolence]

6.6 Publications


Valuing privacy and transparency [ORCID]


On “The Impact Factor Fallacy” [The Scientist]